Philip A. Mock

7.8k citations

115 papers · 5.8k indexed · 2 hit papers · h-index 40

Co-authors: Timothy D. Mastro Suphak Vanichseni Kachit Choopanya Nancy L. Young Rutt Chuachoowong Janet M. McNicholl Frits van Griensven Nathan Shaffer
Topics: HIV/AIDS Research and Interventions (73 papers)HIV, Drug Use, Sexual Risk (49 papers)HIV Research and Treatment (46 papers)
Cited by: Virology Infectious Diseases Epidemiology
Journals: The LancetSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Thailand United States Australia

In The Last Decade

Philip A. Mock

115 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

2013 1.1k citations Kachit Choopanya, Michael Martin et al. profile →
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial

1999 561 citations Nathan Shaffer, Rutt Chuachoowong et al. profile →

Peers

Countries citing papers authored by Philip A. Mock

Since Specialization

Citations

This map shows the geographic impact of Philip A. Mock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Mock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Mock more than expected).

Fields of papers citing papers by Philip A. Mock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Mock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Mock. The network helps show where Philip A. Mock may publish in the future.

Co-authorship network of co-authors of Philip A. Mock

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Mock. A scholar is included among the top collaborators of Philip A. Mock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Mock. Philip A. Mock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent declines in HIV infections at Silom Community Clinic Bangkok, Thailand corresponding to HIV prevention scale up: An open cohort assessment 2005–2018 2020 ·International Journal of Infectious Diseases ·Sarika Pattanasin,Frits van Griensven,Philip A. Mock,Wichuda Sukwicha,(unknown),(unknown),Siobhán O’Connor,Andrew C. Hickey,Taweesap Siraprapasiri,Joseph Woodring,Pachara Sirivongrangson,Timothy H. Holtz,Eileen F. Dunne	9
2	Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention Effectiveness Study 2019 ·SHILAP Revista de lepidopterología ·Andrea L. Wirtz,Brian W. Weir,(unknown),Pachara Sirivongrangson,Tareerat Chemnasiri,Eileen F. Dunne,Anchalee Varangrat,Andrew C. Hickey,Michele R. Decker,Stefan Baral,Kamolnetr Okanurak,Patrick S. Sullivan,Rachel Valencia,Michael C. Thigpen,Timothy H. Holtz,Philip A. Mock,Betsy L. Cadwell,Adeola Adeyeye,James F. Rooney,Chris Beyrer,(unknown)	5
3	Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kimberly Page,Judith I. Tsui,Lisa Maher,Kachit Choopanya,Suphak Vanichseni,Philip A. Mock,Connie Celum,Michael Martin	30
4	Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand 2015 ·PLoS ONE ·Pravan Suntharasamai,Michael Martin,Kachit Choopanya,Suphak Vanichseni,Udomsak Sangkum,(unknown),Wanna Leelawiwat,(unknown),Philip A. Mock,(unknown),Manoj Leethochawalit,Sithisat Chiamwongpaet,Roman Gvetadze,Janet M. McNicholl,Lynn Paxton,Somyot Kittimunkong,Marcel E. Curlin	16
5	HIVQUAL-T: monitoring and improving HIV clinical care in Thailand, 2002-08 2012 ·International Journal for Quality in Health Care ·Sombat Thanprasertsuk,Somsak Supawitkul,Rangsima Lolekha,(unknown),Bruce Agins,(unknown),Kimberley Fox,(unknown),(unknown),Robert H. Gass,Nicole Simmons,Achara Chaovavanich,(unknown),(unknown),Somsak Akksilp,Philip A. Mock,Sanchai Chasombat,Cheewanan Lertpiriyasuwat,Jordan W. Tappero,William C. Levine	16
6	Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence 2011 ·PLoS ONE ·Janet M. McNicholl,J. Steven McDougal,Punneeporn Wasinrapee,Bernard M. Branson,Michael Martin,Jordan W. Tappero,Philip A. Mock,Timothy A. Green,Dale J. Hu,Bharat Parekh,(unknown)	9
7	Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003–2007 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Frits van Griensven,Anchalee Varangrat,Wipas Wimonsate,(unknown),(unknown),Tareerat Chemnasiri,(unknown),Praphan Phanuphak,Philip A. Mock,(unknown),Janet M. McNicholl,Tanarak Plipat	126
8	Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003 2010 ·International Journal of Drug Policy ·Michael Martin,Suphak Vanichseni,Pravan Suntharasamai,Philip A. Mock,Frits van Griensven,Punnee Pitisuttithum,Jordan W. Tappero,Sithisat Chiamwongpaet,Udomsak Sangkum,Dwip Kitayaporn,Marc Gurwith,Kachit Choopanya	30
9	Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999–2003 2009 ·Addiction ·Pravan Suntharasamai,Michael Martin,Suphak Vanichseni,Frits van Griensven,Philip A. Mock,Punnee Pitisuttithum,Jordan W. Tappero,Udomsak Sangkum,Dwip Kitayaporn,Marc Gurwith,Kachit Choopanya	26
10	Dried blood spots for the diagnosis and quantitation of HIV-1: Stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand 2008 ·Journal of Virological Methods ·Wanna Leelawiwat,Nancy L. Young,(unknown),C Y Ou,Mary Culnane,(unknown),Naris Waranawat,Punneeporn Wasinrapee,Philip A. Mock,Jordan W. Tappero,(unknown)	60
11	Acceptability of Carraguard vaginal gel use among Thai couples 2006 ·AIDS ·Sara Whitehead,Peter H. Kilmarx,Kelly Blanchard,Chomnad Manopaiboon,Supaporn Chaikummao,Barbara Friedland,Jullapong Achalapong,(unknown),Philip A. Mock,Sombat Thanprasertsuk,Jordan W. Tappero	38
12	Sexual Risk Reduction in a Cohort of Injecting Drug Users in Bangkok, Thailand 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Suphak Vanichseni,Don C. Des Jarlais,Kachit Choopanya,Philip A. Mock,Dwip Kitayaporn,(unknown),(unknown),Dale J. Hu,Frits van Griensven,Timothy D. Mastro,Jordan W. Tappero	21
13	HIV Type 1 Incidence Estimates by Detection of Recent Infection from a Cross-Sectional Sampling of Injection Drug Users in Bangkok: Use of the IgG Capture BED Enzyme Immunoassay 2003 ·AIDS Research and Human Retroviruses ·Dale J. Hu,Suphak Vanichseni,Philip A. Mock,Nancy L. Young,Trudy Dobbs,Robert H. Byers,Kachit Choopanya,Frits van Griensven,Dwip Kitayaporn,J. Steven McDougal,Jordan W. Tappero,Timothy D. Mastro,Bharat Parekh	60
14	Evaluation of a Sensitive/Less Sensitive Testing Algorithm Using the bioMérieux Vironostika-LS Assay for Detecting Recent HIV-1 Subtype B' or E Infection in Thailand 2003 ·AIDS Research and Human Retroviruses ·(unknown),Dale J. Hu,Richard Byers,Suphak Vanichseni,Nancy L. Young,Robert Nelson,Philip A. Mock,Kachit Choopanya,Robert S. Janssen,Timothy D. Mastro,Joanne V. Mei	60
15	Higher Viral Loads and Other Risk Factors Associated With HIV-1 Seroconversion During a Period of High Incidence Among Injection Drug Users in Bangkok 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Dale J. Hu,Shambavi Subbarao,Suphak Vanichseni,Philip A. Mock,Frits van Griensven,Robert Nelson,Lily H. P. Nguyen,Dwip Kitayaporn,Nancy L. Young,Don C. Des Jarlais,Richard Byers,Kachit Choopanya,Timothy D. Mastro	19
16	HIV Seroconversion During Pregnancy and Risk for Mother-to-Infant Transmission 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anuvat Roongpisuthipong,Wimol Siriwasin,R. J. Simonds,(unknown),Nirun Vanprapar,Chantapong Wasi,(unknown),Philip A. Mock,Nancy L. Young,Bharat Parekh,Timothy D. Mastro,Nathan Shaffer	19
17	Evaluating a new strategy for prophylaxis to prevent Pneumocystis carinii pneumonia in HIV-exposed infants in Thailand 2000 ·AIDS ·(unknown),Rutt Chuachoowong,Tawee Chotpitayasunondh,Sanay Chearskul,Nirun Vanprapar,Naris Waranawat,Philip A. Mock,Nathan Shaffer,R. J. Simonds	8
18	Short‐Course Antenatal Zidovudine Reduces Both Cervicovaginal Human Immunodeficiency Virus Type 1 RNA Levels and Risk of Perinatal Transmission 2000 ·The Journal of Infectious Diseases ·Rutt Chuachoowong,Nathan Shaffer,Wimol Siriwasin,Pongsakdi Chaisilwattana,Nancy L. Young,Philip A. Mock,Sanay Chearskul,Naris Waranawat,(unknown),John M. Karon,R. J. Simonds,Timothy D. Mastro,(unknown)	103
19	Differences in sexual behaviour between HIV-infected pregnant women and their husbands in Bangkok, Thailand 1999 ·AIDS Care ·(unknown),Nathan Shaffer,(unknown),(unknown),Philip A. Mock,(unknown),C Bhadrakom,Timothy D. Mastro	21
20	PEAPS-Q: A Questionnaire to measure the Psychosocial Effects of Having an Abnormal Pap Smear 1995 ·Journal of Clinical Epidemiology ·(unknown),Les Irwig,Brian Oldenburg,Judy M. Simpson,Philip A. Mock,Allison Boyes,(unknown),Edith Weisberg,Julia Shelley	56

About Philip A. Mock

Philip A. Mock is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 115 papers that have together received 5.8k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (73 papers), HIV, Drug Use, Sexual Risk (49 papers) and HIV Research and Treatment (46 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (4.1k citations) and Epidemiology (3.3k citations). Philip A. Mock has collaborated with scholars based in Thailand, United States and Australia. Frequent co-authors include Timothy D. Mastro, Suphak Vanichseni, Kachit Choopanya, Nancy L. Young, Rutt Chuachoowong, Janet M. McNicholl, Frits van Griensven, Nathan Shaffer, Michael Martin and Marcel E. Curlin. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact